Delivery Order SPE2DB25D3006-SPE2DB25FXKMA
- Not listed
- The Defense Logistics Agency awarded a $2,697.75 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's ability to compete successfully in open federal procurement. Performance will be completed by July 21, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injectables on September 8, 2025, with a ceiling value of $1,576.12 and ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections with a ceiling value of $6,055.29. This competitively awarded, firm fixed-price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,906.45. The award, made on August 8, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. This non-competitive set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete...
- The Defense Logistics Agency awarded a $35,358.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections. The contract, designated as a non-set-aside competitive award, calls for completion by August 18, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,231.11 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $35,751.17 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,109.75 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $7,724.28. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award is issued as a child...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKMADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a ceiling value of $2,669.03 and an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Zepbound reflects the company's role in supplying diabetes and weight management medications to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/17/25 |